FDA inspection
Homayoon (nmi) Khanlou, M.D.: FDA inspection ending Aug 18, 2017
FDA inspection 1022403 · Voluntary Action Indicated (VAI) · Beverly Hills, CA
Key facts
| Inspection ID | 1022403 |
|---|---|
| Firm | Homayoon (nmi) Khanlou, M.D. |
| FEI number | 3006760992 |
| Address | 99 N La Cienega Blvd Ste 200 |
| City | Beverly Hills |
| State | CA |
| ZIP | 90211 |
| Country | United States |
| Fiscal year | 2017 |
| Inspection end date | Aug 18, 2017 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data